HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy].

Abstract
A 63-year-old man was admitted to our hospital for acute heart failure. A chest CT scan revealed a large anterior mediastinal mass and pericardial effusion. Percutaneous needle biopsy showed that the mass was an advanced thymic cancer (squamous cell carcinoma). The patient was treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy (44 Gy). There was no severe toxicity except for grade 4 neutropenia. After 3 courses of chemotherapy, the mass showed an approximately 81% reduction in tumor size and disappearance of the pericardial effusion. Finally, the thymic cancer and small pulmonary metastatic lesions were all resected. This concurrent chemoradiotherapy can be effective against inoperable squamous cell carcinoma of the thymus.
AuthorsKyoichi Kaira, Rieko Watanabe, Atsushi Takise, Katsuaki Endou, Mitsuhiro Kamiyoshihara, Masatomo Mori
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 32 Issue 12 Pg. 1989-92 (Nov 2005) ISSN: 0385-0684 [Print] Japan
PMID16282742 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Etoposide
  • Carboplatin
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carboplatin (administration & dosage)
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy, secondary, surgery)
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Etoposide (administration & dosage)
  • Humans
  • Lung Neoplasms (secondary, surgery)
  • Male
  • Middle Aged
  • Thymectomy
  • Thymus Neoplasms (drug therapy, pathology, radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: